Anti-allergy asthma-relieving tea

Abstract

The invention provides an anti-allergy asthma-relieving tea. The anti-allergy asthma-relieving tea is characterized by comprising the following raw materials by weight: 15 to 20 parts of trichosanthes root, 20 to 25 parts of milkvetch root, 15 to 20 parts of cicada slough, 18 to 23 parts of bitter apricot kernel, 9 to 15 parts of balloonflower root, 10 to 13 parts of hogfennel root, 15 to 25 parts of Zhejiang fritillaria bulb, 15 to 18 parts of red sage root, 20 to 25 parts of pseudostellaria root, 20 to 28 parts of licorice, 15 to 20 parts of ginger processed pinellia tuber and 20 to 30 parts of heartleaf houttuynia herb. The above-mentioned 12 traditional Chinese medicines are easily available and need low cost; the anti-allergy asthma-relieving tea exerts the effects of diffusing the lung, relieving cough, eliminating phlegm by cooling and reducing phlegm to depress Qi when people drinking the tea; and the anti-allergy asthma-relieving tea is convenient to use and easy to carry, causes no anaphylactic reaction and has no toxic and side effects.

Description

technical field [0001] The invention relates to a health-care tea, in particular to an anti-allergy and anti-asthma tea. Background technique [0002] Allergic asthma is a chronic airway inflammation involving a variety of cells, especially mast cells, eosinophils, and T lymphocytes. In susceptible individuals, this inflammation can cause recurrent episodes of wheezing, shortness of breath, chest tightness, and / or ) cough and other symptoms, mostly occur at night and (or) early morning, and the airway is more responsive to various stimuli, but the symptoms can be relieved by themselves or after treatment. The prevalence of allergic asthma in my country is about 1%, and children can reach 3%. According to estimates, there are more than 10 million asthma patients in the country. According to the survey, there are at least 20 million asthma patients in my country, but only less than 5% of them have received standardized treatment. In China, the key to controlling asthma is to ...

AI Technical Summary

Problems solved by technology

According to the survey, there are at least 20 million asthma patients in my country, but only less than 5% of them have received standardized treatment. In China, the key to controlling asthma is to actively encourage patients to seek regular treatment options. Most of the existing drugs are Synthesis of chemical agents, high manufacturing costs, and damage to human immunity